抽动秽语综合征与慢性抽动障碍和代谢及心血管疾病风险相关
TS/CTD患者发生任何代谢或心血管疾病的风险高于一般人群(aHR 1.99,95%CI 1.90–2.09)及同胞对照(aHR 1.37,95%CI 1.24–1.51),风险从儿童期即显现,且男性高于女性。
要点
- TS/CTD患者代谢及心血管疾病风险显著升高,同胞对照分析提示存在家族外因素。
- 肥胖(aHR 2.76)和2型糖尿病(aHR 1.67)风险明显增加,男性风险高于女性。
- 风险自儿童期(8岁前)即已显现,合并注意缺陷多动障碍(ADHD)者风险更高。
核心结论
- TS和CTD与代谢及心血管疾病风险显著相关,需终身关注心血管代谢健康。
研究设计与样本
- 其中7,804人(男性5,964人,76.4%;首次诊断中位年龄13.3岁,IQR 9.9–21.3)有TS或CTD专科诊断。
主要发现
- TS/CTD患者任何代谢或心血管疾病风险高于一般人群(aHR 1.99;95%CI 1.90–2.09)及同胞对照(aHR 1.37;95%CI 1.24–1.51)。
- 具体风险:肥胖aHR 2.76(95%CI 2.47–3.09),2型糖尿病aHR 1.67(95%CI 1.42–1.96),循环系统疾病aHR 1.76(95%CI 1.67–1.86)。
- 男性任何心血管代谢疾病风险aHR 2.13(95%CI 2.01–2.26),女性aHR 1.79(95%CI 1.64–1.96);肥胖风险男性aHR 3.24(95%CI 2.83–3.70),女性aHR 1.97(95%CI 1.59–2.44)。
- 风险从儿童期即显现(8岁时组间已显著不同);排除合并ADHD者后风险降低(aHR 1.52;95%CI 1.42–1.62),排除其他合并症不影响结果。
- 与未使用抗精神病药者相比,抗精神病药治疗时间>1年者代谢及心血管疾病风险显著较低。
临床怎么用
- 对TS/CTD患者应终身监测心血管代谢健康,尤其关注合并ADHD者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: There are limited data concerning the risk of metabolic and cardiovascular disorders among individuals with Tourette syndrome (TS) or chronic tic disorder (CTD). OBJECTIVE: To investigate the risk of metabolic and cardiovascular disorders among individuals with TS or CTD over a period of 40 years. DESIGN, SETTINGS, AND PARTICIPANTS: This longitudinal population-based cohort study included all individuals living in Sweden between January 1, 1973, and December 31, 2013. Families with clusters of full siblings discordant for TS or CTD were further identified. Data analyses were conducted from August 1, 2017, to October 11, 2018. EXPOSURES: Previously validated International Classification of Diseases diagnoses of TS or CTD in the Swedish National Patient Register. MAIN OUTCOMES AND MEASURES: Registered diagnoses of obesity, dyslipidemia, hypertension, type 2 diabetes, and cardiovascular diseases (including ischemic heart diseases, arrhythmia, cerebrovascular diseases and transient ischemic attack, and arteriosclerosis). RESULTS: Of the 14 045 026 individuals in the cohort, 7804 individuals (5964 males [76.4%]; median age at first diagnosis, 13.3 years [interquartile range, 9.9-21.3 years]) had a registered diagnosis of TS or CTD in specialist care. Of 2 675 482 families with at least 2 singleton full siblings, 5141 families included siblings who were discordant for these disorders. Individuals with TS or CTD had a higher risk of any metabolic or cardiovascular disorders compared with the general population (hazard ratio adjusted by sex and birth year [aHR], 1.99; 95% CI, 1.90-2.09) and sibling controls (aHR for any disorder, 1.37; 95% CI, 1.24-1.51). Specifically, individuals with TS or CTD had higher risks for obesity (aHR, 2.76; 95% CI, 2.47-3.09), type 2 diabetes (aHR, 1.67; 95% CI, 1.42-1.96), and circulatory system diseases (aHR, 1.76; 95% CI, 1.67-1.86). The risk of any cardiometabolic disorder was significantly greater in males than in females (aHR, 2.13; 95% CI, 2.01-2.26 vs aHR, 1.79; 95% CI, 1.64-1.96), as was the risk of obesity (aHR, 3.24; 95% CI, 2.83-3.70 vs aHR, 1.97; 95% CI, 1.59-2.44). The risks were already evident from childhood (the groups were significantly different by age 8 years) and were significantly reduced with the exclusion of individuals with comorbid attention-deficit/hyperactivity disorder (aHR, 1.52; 95% CI, 1.42-1.62), while excluding other comorbidities did not significantly affect the results. Compared with patients with TS or CTD who were not taking antipsychotics, patients with a longer duration of antipsychotic treatment (>1 year) had significantly lower risks of metabolic and cardiovascular disorders. CONCLUSIONS AND RELEVANCE: The findings of this study suggest that TS and CTD are associated with a substantial risk of metabolic and cardiovascular disorders. The results highlight the importance of carefully monitoring cardiometabolic health in patients with TS or CTD across the lifespan, particularly in those with comorbid attention-deficit/hyperactivity disorder.
引用
- Brander G, Isomura K, Chang Z, et al. Association of Tourette Syndrome and Chronic Tic Disorder With Metabolic and Cardiovascular Disorders. JAMA Neurol. 2019. PMID: 30640363. doi:10.1001/jamaneurol.2018.4279
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。